AMPE (Ampio Pharmaceuticals) Other Operating Expense: $0.00 Mil (TTM As of Dec. 2023)


What is Ampio Pharmaceuticals Other Operating Expense?

Ampio Pharmaceuticals AMPE -71.39% Other Operating Expense is $0.00 Mil as of Dec. 2023.

Ampio Pharmaceuticals's Other Operating Expense for the three months ended in Dec. 2023 was $-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Ampio Pharmaceuticals's quarterly Other Operating Expense declined from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.00 Mil) and declined from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($-0.00 Mil).

Ampio Pharmaceuticals's annual Other Operating Expense stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Ampio Pharmaceuticals Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Other Operating Expense Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.01 0.00 0.00 0.00

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

Ampio Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.00 Mil mean?
Ampio Pharmaceuticals (AMPE) has a Other Operating Expense of $0.00 Mil as of Dec. 2023. Other operating expenses that a company records on its income statement. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Other Operating Expense too high?
Ampio Pharmaceuticals' current Other Operating Expense is $0.00 Mil.
How does Ampio Pharmaceuticals' Other Operating Expense compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Other Operating Expense of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Other Operating Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (AMPE) has a current Other Operating Expense of $0.00 Mil. The current Other Operating Expense is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Ampio Pharmaceuticals (AMPE), the current Other Operating Expense is $0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).